Navigation Links
Winnick Family Clinical Research Center Celebrates 6th Anniversary
Date:3/3/2008

Center's Innovative Research Program Continues to Draw Accolades from

Cedars-Sinai Medical Community

LOS ANGELES, March 3 /PRNewswire/ -- The Winnick Family Clinical Research Center celebrated its sixth anniversary this month and announced that it has 60 active research protocols at the Center in 2008, representing 210 clinical researchers at Cedars-Sinai Medical Center. These researchers are active in areas ranging from women's health and the genetics of common diseases to mitochondrial genetics, insulin resistance and AIDS. The Winnick Family Foundation, founded by business visionary Gary Winnick, funds the Winnick Family Clinical Research Center at Cedars-Sinai Medical Center and the critical research that takes place at its facility.

"We continue to be hugely encouraged and inspired in our research by the generous support from the Winnick Family Foundation," said Dr. Shlomo Melmed, senior vice president academic affairs of Cedars-Sinai Medical Center. "With the breakthroughs in genetic research now coming faster and gaining in practical medical relevance all the time, the generous donations made to our genetic research programs by Gary Winnick through his foundation to the Winnick Family Clinical Research Center are enabling us to explore whole new treatment protocols with the potential to improve quality of life and life expectancy for thousands of patients suffering from a wide spectrum of illnesses. We look forward to continuing our dynamic relationship with Gary and the Winnick Family Foundation for many years to come."

"It's been an honor for us to make a contribution toward the immensely important research work being carried out at Cedars-Sinai," said Gary Winnick, founder and president of the Winnick Family Foundation. "Since the beginning of our relationship with the Center, it was crucial that the innovative, exciting work being carried out with the support of the Winnick Family Foundation give special emphasis to patient-oriented research. We are confident that this is the cutting-edge of clinical research. Our hopes have been amply rewarded by the Center's groundbreaking research into some of the afflictions that are among the greatest scourges of our society. It's wonderful to see young, gifted scientists taking up the torch of pioneering research in the Human Genome era, and we can't wait to see what the 2008 Winnick Clinical Scholars and larger body of researchers at the Winnick Family Clinical Research Center will be working on over the coming year."

The Winnick Family Clinical Research Center is a fully staffed center for clinical research active in all major clinical departments, utilizing administration, nursing, and nutritional support, along with core laboratory services in sample processing, tissue culture, genome screening and bioinformatics.


'/>"/>
SOURCE Winnick Family Clinical Research Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. IsoTis Receives FDA Clearance for Accell Family of Products
2. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
3. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
4. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
5. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
6. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):